HS Icon Medicaments nes, formulated, in bulk

300390 (Harmonized System 1992 for 6-digit)

Overview This page contains the latest trade data of Medicaments nes, formulated, in bulk. In 2019, Medicaments nes, formulated, in bulk were the world's 341st most traded product, with a total trade of $8.94B. Between 2018 and 2019 the exports of Medicaments nes, formulated, in bulk decreased by -40.1%, from $14.9B to $8.94B. Trade in Medicaments nes, formulated, in bulk represent 0.049% of total world trade.

Exports In 2019 the top exporters of Medicaments nes, formulated, in bulk  were Netherlands ($2.26B), United States ($1.08B), Germany ($668M), Switzerland ($541M), and Spain ($411M).

Imports In 2019 the top importers of Medicaments nes, formulated, in bulk were United Kingdom ($2.28B), Ireland ($1.25B), Germany ($644M), United States ($515M), and Netherlands ($418M).

Tariffs In 2018 the average tariff for Medicaments nes, formulated, in bulk was 4.82%, making it the 4282nd lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Medicaments nes, formulated, in bulk are Iran (34.5%), Belize (12.7%), Nepal (11.6%), Barbados (11.2%), and Pakistan (10.8%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking Medicaments nes, formulated, in bulk ranks 1367th in the Product Complexity Index (PCI).

Description A medicament is a chemical preparation used as a drug to prevent, diagnose, or treat an ailment. Medicaments are often used to relieve symptoms or to suppress the specific activity of a disease.

Historical Data

#permalink to section

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2019): Netherlands, $2.26B

Top Destination (2019): United Kingdom, $2.28B

Medicaments nes, formulated, in bulk are the world's 341st most traded product.

In 2019, the top exporters of Medicaments nes, formulated, in bulk were Netherlands ($2.26B), United States ($1.08B), Germany ($668M), Switzerland ($541M), and Spain ($411M).

In 2019, the top importers of Medicaments nes, formulated, in bulk were United Kingdom ($2.28B), Ireland ($1.25B), Germany ($644M), United States ($515M), and Netherlands ($418M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2018 -  2019): Netherlands, $596M

Top Destination Growth (2018 - 2019): United Kingdom, $379M

Between 2018 and 2019, the exports of Medicaments nes, formulated, in bulk grew the fastest in Netherlands ($596M), Portugal ($110M), Denmark ($101M), Switzerland ($87M), and Sweden ($50.7M).

Between 2018 and 2019, the fastest growing importers of Medicaments nes, formulated, in bulk were United Kingdom ($379M), Spain ($130M), Russia ($79.4M), Portugal ($48.7M), and Kazakhstan ($21.8M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

Value

This chart shows the evolution of the market concentration of exports of Medicaments nes, formulated, in bulk.

In 2019,  market concentration measured using Shannon Entropy, was 4.22. This means that most of the exports of Medicaments nes, formulated, in bulk are explained by 18 countries.

Explore Visualizations

TOP NET EXPORTER (2019): Netherlands, $1.85B

TOP NET IMPORTER (2019): United Kingdom, $2.13B

This map shows which countries export or import more of Medicaments nes, formulated, in bulk. Each country is colored based on the difference in exports and imports of Medicaments nes, formulated, in bulk during 2019.

In 2019, the countries that had a largest trade value in exports than in imports of Medicaments nes, formulated, in bulk were Netherlands ($1.85B), United States ($563M), Switzerland ($371M), Israel ($313M), and France ($260M).

In 2019, the countries that had a largest trade value in imports than in exports of Medicaments nes, formulated, in bulk were United Kingdom ($2.13B), Ireland ($1.07B), Russia ($185M), Algeria ($118M), and Saudi Arabia ($97.4M).

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Medicaments nes, formulated, in bulk was 4.82%. The countries with the highest tariffs for importing Medicaments nes, formulated, in bulk were Iran (34.5%), Belize (12.7%), Nepal (11.6%), Barbados (11.2%), and Pakistan (10.8%).

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.